======= DMRT2 ======= == Gene Information == * **Official Symbol**: DMRT2 * **Official Name**: doublesex and mab-3 related transcription factor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10655|10655]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5R5|Q9Y5R5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DMRT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DMRT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604935|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the DMRT gene family, sharing a DM DNA-binding domain with Drosophila 'doublesex' (dsx) and C. elegans mab3, genes involved in sex determination in these organisms. Also, this gene is located in a region of the human genome (chromosome 9p24.3) associated with gonadal dysgenesis and XY sex reversal. Hence this gene is one of the candidates for sex-determining gene(s) on chr 9. [provided by RefSeq, Apr 2010]. * **UniProt Summary**: Transcriptional activator that directly regulates early activation of the myogenic determination gene MYF5 by binding in a sequence-specific manner to the early epaxial enhancer element of it. Involved in somitogenesis during embryogenesis and somite development and differentiation into sclerotome and dermomyotome. Required for the initiation and/or maintenance of proper organization of the sclerotome, dermomyotome and myotome (By similarity). {ECO:0000250}. |DM| |regulation of myotome development| |positive regulation of myotome development| |regulation of somitogenesis| |positive regulation of embryonic development| |embryonic skeletal system development| |regulation of embryonic development| |RNA polymerase II regulatory region sequence-specific DNA binding| |cellular component| |skeletal system development| |chordate embryonic development| |embryo development ending in birth or egg hatching| |molecular function| |protein homodimerization activity| |embryo development| |regulation of anatomical structure morphogenesis| |positive regulation of transcription by RNA polymerase II| |positive regulation of developmental process| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp495|IWR1 50μM R08 exp495]]|-1.79| |[[:results:exp37|Wortmannin 0.5μM R00 exp37]]|-1.79| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13486 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}